Clinical Trial Location: Australia

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib (STOP-LTR)

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa